Inamed obesity device moves to pre-trial phase:
This article was originally published in Clinica
Executive Summary
Inamed's patent and royalty dispute with Dr Lubomyr Kuzmak and Ethicon Endo-Surgery over the Lap-Band obesity product is moving to the pre-trial discovery phase. The move comes after the US District Court for the Central District of California ruled that an agreement dating from January 2000 - which Inamed believed settled the dispute - was unenforceable. The dispute will now centre on issues of non-infringement, invalidity and unenforceability of the Kuzmak patents, as well as Dr Kuzmak's claim for royalties, the Santa Barbara, California company says.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.